✦ LIBER ✦

Benefit–Risk Analysis of Glatiramer Acetate for Relapsing-Remitting and Clinically Isolated Syndrome Multiple Sclerosis

✍ Scribed by Nawab Qizilbash; Ignacio Mendez; Rainel Sanchez-de la Rosa

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Histogram analysis of diffusion measures

✍ Chun Shui Yu; Fu Chun Lin; Yaou Liu; Yunyun Duan; Hao Lei; Kun Cheng Li 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Benefits of glatiramer acetate on disabi

✍ C Liu; L.D Blumhardt 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Sustained clinical benefits of glatirame

✍ Johnson, K P; Brooks, B R; Ford, C C; Goodman, A; Guarnaccia, J; Lisak, R P; Mye 📂 Article 📅 2000 🏛 SAGE Publications 🌐 English ⚖ 251 KB

Glatiramer Acetate: A Review of Its Use

✍ Scott, Lesley J. 📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 448 KB

Cost analysis of glatiramer acetate vs.

✍ Rainel Sanchez-de la Rosa, Eliazar Sabater, Miguel A Casado 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 206 KB

PND30 Cost Analysis of Glatiramer Acetat

✍ Sánchez-de la Rosa, R.; Sabater, E.; Casado, M.A. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB